TY - JOUR
T1 - Effect of the first year of COVID-19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system
AU - Bermúdez-Forero, María Isabel
AU - Soto-Viáfara, Jonathan Andrés
AU - Gardeazábal-Acuña, Paula Andrea
AU - Anzola-Samudio, Diego Alexander
AU - García-Otálora, Michel Andrés
N1 - Publisher Copyright:
© 2021 British Blood Transfusion Society.
PY - 2021/10/24
Y1 - 2021/10/24
N2 - Objective: This work aimed to establish the effects of the COVID-19 pandemic on blood collection and blood product usage at the end of the first year. Background: The arrival of SARS-CoV-2 to Colombia on March 6, 2020, triggered closure of borders and mandatory lockdown from March 23, 2020. Methods/Materials: The Colombian National Institute of Health administers the National database of confirmed cases of SARS-CoV-2 and the National Haemovigilance System. We examined positive SARS-CoV-2 cases identified between March 6, 2020, and March 6, 2021, using positive RT-PCR testing (72.8%) or reactive antigen (27.2%). We also analysed accepted and deferred donors' information provided by 100% of blood banks and transfused patients notified by 83% of health care facilities nationwide, between March 1, 2019, to February 28, 2021. Results: Colombia registered 2 273 245 SARS-CoV-2 cases. From these, 60 412 people died from COVID-19 (2.7%) and 2 172 418 individuals recovered (95.6%). There were 11 659 216 SARS-CoV-2 processed samples nationwide. People between the ages of 20 and 39 years concentrated 44.4% of the SARS-CoV-2 cases. There were 773 569 blood donations, mainly from a 20-39-year-old population (60.5%). The pandemic caused a reduction of 155 393 blood donations (16.7%) and 51 823 total deferrals (33.7%). An 18.4% drop in volunteer donors and a 37.3% increase in donations from family/replacements members were observed. There were 399 453 transfused patients and 1 179 895 blood components administered (−8.7% and − 13.9% compared to March 2019–February 2020). Conclusion: Mandatory lockdowns in Colombia decreased blood collection and usage, resulting in a reduction of blood components transfused to individual patients.
AB - Objective: This work aimed to establish the effects of the COVID-19 pandemic on blood collection and blood product usage at the end of the first year. Background: The arrival of SARS-CoV-2 to Colombia on March 6, 2020, triggered closure of borders and mandatory lockdown from March 23, 2020. Methods/Materials: The Colombian National Institute of Health administers the National database of confirmed cases of SARS-CoV-2 and the National Haemovigilance System. We examined positive SARS-CoV-2 cases identified between March 6, 2020, and March 6, 2021, using positive RT-PCR testing (72.8%) or reactive antigen (27.2%). We also analysed accepted and deferred donors' information provided by 100% of blood banks and transfused patients notified by 83% of health care facilities nationwide, between March 1, 2019, to February 28, 2021. Results: Colombia registered 2 273 245 SARS-CoV-2 cases. From these, 60 412 people died from COVID-19 (2.7%) and 2 172 418 individuals recovered (95.6%). There were 11 659 216 SARS-CoV-2 processed samples nationwide. People between the ages of 20 and 39 years concentrated 44.4% of the SARS-CoV-2 cases. There were 773 569 blood donations, mainly from a 20-39-year-old population (60.5%). The pandemic caused a reduction of 155 393 blood donations (16.7%) and 51 823 total deferrals (33.7%). An 18.4% drop in volunteer donors and a 37.3% increase in donations from family/replacements members were observed. There were 399 453 transfused patients and 1 179 895 blood components administered (−8.7% and − 13.9% compared to March 2019–February 2020). Conclusion: Mandatory lockdowns in Colombia decreased blood collection and usage, resulting in a reduction of blood components transfused to individual patients.
UR - http://www.scopus.com/inward/record.url?scp=85117754413&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117754413&partnerID=8YFLogxK
U2 - 10.1111/tme.12828
DO - 10.1111/tme.12828
M3 - Article
C2 - 34693573
AN - SCOPUS:85117754413
SN - 0958-7578
JO - Transfusion Medicine
JF - Transfusion Medicine
ER -